A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Target Recruit Count
- 48
- Registration Number
- NCT06807463
- Locations
- 🇺🇸
Teva Investigational Site 12127, Winston-Salem, North Carolina, United States
🇺🇸Teva Investigational Site 12131, Colorado Springs, Colorado, United States
🇺🇸Teva Investigational Site 12126, Miami Lakes, Florida, United States
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- First Posted Date
- 2024-10-29
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 724
- Registration Number
- NCT06664619
- Locations
- 🇺🇸
Teva Investigational Site 12142, Lakewood, Colorado, United States
🇺🇸Teva Investigational Site 12110, Jersey City, New Jersey, United States
🇺🇸Teva Investigational Site 12107, Rock Hill, South Carolina, United States
Mass Balance Clinical Trial With TEV-56286
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT06627231
- Locations
- 🇳🇱
Teva Investigational Site 38189, Groningen, Netherlands
A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT06625177
- Locations
- 🇺🇸
Teva Investigational Site 12054, Portland, Oregon, United States
🇺🇸Teva Investigational Site 12043, Scottsdale, Arizona, United States
🇺🇸Teva Investigational Site 12052, Hot Springs, Arkansas, United States
A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06568237
- Locations
- 🇺🇸
Teva Investigational Site 15547, Washington, District of Columbia, United States
🇮🇹Teva Investigational Site 30299, Bologna, Italy
🇩🇪Teva Investigational Site 32822, Dusseldorf, Germany
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT06480552
- Locations
- 🇺🇸
Teva Investigational Site 12017, Los Angeles, California, United States
🇺🇸Teva Investigational Site 12021, Lake Mary, Florida, United States
🇺🇸Teva Investigational Site 12016, Chicago, Illinois, United States
Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder
- Conditions
- Schizophrenia, Schizoaffective Disorder
- Interventions
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 91
- Registration Number
- NCT06319170
- Locations
- 🇺🇸
Teva Investigational Site 15730, Los Alamitos, California, United States
🇺🇸Teva Investigational Site 15727, Hollywood, Florida, United States
🇺🇸Teva Investigational Site 15729, Atlanta, Georgia, United States
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT06315283
- Locations
- 🇺🇸
Teva Investigational Site 15739, Los Alamitos, California, United States
🇺🇸Teva Investigational Site 15740, Torrance, California, United States
🇺🇸Teva Investigational Site 15738, Hollywood, Florida, United States
Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06290102
- Locations
- 🇺🇸
Teva Investigational Site 12010, Mobile, Alabama, United States
🇺🇸Teva Investigational Site 12003, Long Beach, California, United States
🇺🇸Teva Investigational Site 12007, Miami, Florida, United States
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT06253546
- Locations
- 🇨🇳
Teva Investigational Site 88056, Xi'an Shi, China
🇨🇳Teva Investigational Site 88046, Shanghai, China
🇨🇳Teva Investigational Site 88050, Wuhan Shi, China